You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Protein-Losing Enteropathies

Showing 1 - 25 of 9,049
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

CD55-Deficient Protein-Losing Enteropathy Trial (Pozelimab)

Available
  • CD55-Deficient Protein-Losing Enteropathy
  • (no location specified)
Aug 14, 2023

Fontan Operation, Protein-Losing Enteropathy, Camostat Mesylate Trial (Camostat mesylate)

Not yet recruiting
  • Fontan Operation
  • +2 more
  • Camostat mesylate
  • (no location specified)
Jul 23, 2022

CD55-deficient Protein-losing Enteropathy, CHAPLE Trial in Bethesda, Pathum Wan, Istanbul (Pozelimab)

Active, not recruiting
  • CD55-deficient Protein-losing Enteropathy
  • CHAPLE
  • Bethesda, Maryland
  • +2 more
Nov 8, 2022

Lymph Re-circulation in Fontan-associated Protein-losing

Enrolling by invitation
  • Dopamine
  • +6 more
    • Ann Arbor, Michigan
      University of Michigan Health System
    Jan 7, 2022

    Paroxysmal Nocturnal Hemoglobinuria (PNH), CD55-deficient Protein-losing Enteropathy (PLE), CD59 Deficiency Trial (Pozelimab)

    Available
    • Paroxysmal Nocturnal Hemoglobinuria (PNH)
    • +2 more
    • (no location specified)
    Jan 28, 2022

    Lymphatic Morphology of Fontan Patients

    Active, not recruiting
    • Lymphatic Abnormality
    • +4 more
    • Non-contrast MRI
    • Cardiopulmonary exercise test
    • Aarhus N, Denmark
      Department of Cardiothoracic and Vascular Surgery
    Apr 27, 2021

    Protein Losing Enteropathy Trial in United States (ODSH at 0.125 mg/kg/h, ODSH at 0.375 mg/kg/h, ODSH at 0.250 mg/kg/h)

    Terminated
    • Protein Losing Enteropathy
    • ODSH at 0.125 mg/kg/h
    • +2 more
    • Los Angeles, California
    • +3 more
    Dec 1, 2021

    Protein Losing Enteropathy In Systemic Lupus Erythematosus

    Not yet recruiting
    • SLE
    • endoscopy
    • (no location specified)
    Aug 14, 2020

    CD55 - Cluster of Differentiation Antigen 55 Deficiency, Primary Intestinal Lymphangiectasis, Protein-Losing Enteropathies Trial

    Unknown status
    • CD55 - Cluster of Differentiation Antigen 55 Deficiency
    • +3 more
    • Eculizumab Injection
    • Istanbul, Turkey
      Marmara University
    Aug 13, 2019

    Overweight and Obesity Trial in Olsztyn (Ketogenic diet, Control diet)

    Not yet recruiting
    • Overweight and Obesity
    • Ketogenic diet
    • Control diet
    • Olsztyn, Poland
    • +1 more
    Dec 7, 2022

    Gastro-esophageal Cancer Trial (Resistance training, Protein supplement)

    Not yet recruiting
    • Gastro-esophageal Cancer
    • Resistance training
    • Protein supplement
    • (no location specified)
    Dec 15, 2022

    Age-Related Macular Degeneration, Neovascular Age-related Macular Degeneration Trial in Tehran (Aflibercept (CinnaGen Co, Iran),

    Completed
    • Age-Related Macular Degeneration
    • Neovascular Age-related Macular Degeneration
    • Aflibercept (CinnaGen Co, Iran)
    • Aflibercept (Regeneron, USA)
    • Tehran, Iran, Islamic Republic of
      Farabi Hospital
    Oct 16, 2022

    Obesity Trial in France (Gastric banding)

    Completed
    • Obesity
    • Gastric banding
    • Colombes, France
    • +5 more
    Oct 27, 2021

    Univentricular Heart Trial in Erlangen (Univentricular Hearts)

    Recruiting
    • Univentricular Heart
    • Univentricular Hearts
    • Erlangen, Germany
      Universitätsklinikum
    Sep 28, 2022

    Obesity Trial in Shanghai (Electroacupuncture, Sham acupuncture, Health education)

    Recruiting
    • Obesity
    • Electroacupuncture
    • +2 more
    • Shanghai, Shanghai, China
      Shanghai Municipal Hospital of Traditional Chinese Medicine
    Nov 8, 2022

    Cerebral Palsy, Hand Functions Trial (TT+CIMT+VR, TT+CIMT, TT)

    Not yet recruiting
    • Cerebral Palsy
    • Hand Functions
    • TT+CIMT+VR
    • +2 more
    • (no location specified)
    Aug 4, 2023

    Frailty Trial in Aberystwyth (Frailty care pathway for older people in a rural primary care setting)

    Withdrawn
    • Frailty
    • Frailty care pathway for older people in a rural primary care setting
    • Aberystwyth, Ceredigion, United Kingdom
      Aberystwyth University
    Apr 28, 2023

    Hemodynamic, Vascular and Muscular Parameters of Exercise

    Recruiting
    • Single-ventricle
    • +5 more
    • Demographic and Clinical Characteristics, Maximal Exercise Capacity, Submaximal Exercise Capacity, Hemodynamic Parameters, Muscle Strength, Muscle Oxygenation, Vascular Function
    • Ankara, Turkey
      Hacettepe University
    Apr 26, 2022

    The Journey of Cow's Milk Protein Allergy in Mexico.

    Completed
    • Cow's Milk Protein Allergy
    • Frisolac Gold Intensive HA
    • Mexico City, Mexico
    • +3 more
    Aug 26, 2021

    NSCLC Trial in Little Rock (EAA+LEU vs total AA, Total AA vs EAA+LEU)

    Unknown status
    • Non-small Cell Lung Cancer
    • EAA+LEU vs total AA
    • Total AA vs EAA+LEU
    • Little Rock, Arkansas
      University of Arkansas for Medical Sciences
    Apr 19, 2019

    Respiratory Symptoms Trial in Korea, Republic of (Lactobacillus plantarum, maltodextrin)

    Recruiting
    • Respiratory Symptoms
    • Lactobacillus plantarum
    • maltodextrin
    • Chuncheon, Korea, Republic of
    • +3 more
    Sep 14, 2022

    Metabolic Syndrome, Morbid Obesity, Hypercholesterolemia Trial in Clearwater (Tetrahydrocannabivarin, Placebo)

    Completed
    • Metabolic Syndrome
    • +3 more
    • Clearwater, Florida
      Hair and Scalp Clinic
    Oct 6, 2022

    Dehydration Trial in Buffalo (Fluid loss and consumption)

    Not yet recruiting
    • Dehydration
    • Fluid loss and consumption
    • Buffalo, New York
      University at Buffalo
    Jun 14, 2023

    Cesarean Section Complications, Tranexamic Acid, Oxytocin Trial in Cairo (Tranexamic acid injection, Oxytocin)

    Recruiting
    • Cesarean Section Complications
    • +3 more
    • Cairo, Kasr El Ainy, Egypt
      faculty of medicine - Cairo university
    Aug 24, 2023

    Obesity or Overweight Trial in China (Cagrilintide, Semaglutide, Placebo Semaglutide)

    Not yet recruiting
    • Obesity or Overweight
    • Beijing, Beijing, China
    • +24 more
    Aug 10, 2023